Sl. No.
|
Title of the Project
|
Name of the Principal Investigator
|
Funding Agency
|
Amount
(in Lakhs)
|
1.
|
Review, revitalize the traditional medicine against ulcers and diabetes
|
Dr B Suresh
|
AICTE
(R & D)
|
10.00
|
2.
|
Modernization of pharmacology laboratory
|
Dr K Elango
|
AICTE
(MODROBS) New Delhi
|
14.00
|
3.
|
Modernization and up gradation of pharmacology laboratory for research excellence in anti-inflammatory and osteoarthritic area
|
Dr K Elango
|
AICTE (MODROBS) New Delhi
|
14.50
|
4.
|
Isolation of bioactive principles from Mucuna pruiens and Tinospora cardifolia and their pharmacological activities in experimental parkinsonism models
|
Dr K Elango
|
AICTE (RPS) New Delhi
|
18.50
|
5.
|
Modernization of molecular pharmacology laboratory for in vitro pharmacokinetic and pharmacodynamic interaction studies
|
Dr K Elango
|
AICTE (MODROBS) New Delhi
|
12.00
|
6.
|
Neuroprotection by nano allosteric potentiators of M1 Muscarinic Acetyl Choline receptor for reversal learning management in Alzheimer’s disease
|
Dr T K Praveen
|
DBT New Delhi
|
72.20
|
7.
|
Fund for Improvement of Science and Technology Infrastructure (FIST)
|
Dr K Elango
|
DST FIST New Delhi
|
84.00
|
8.
|
Death receptor-5 targeted lipid nanoparticles of ?-secretase inhibitor for simultaneous targeting of breast cancer cells and cancer stem cells
|
Dr T K Praveen
|
DBT –N E Twinning Project
|
45.73
|
9.
|
Adipocyte specific delivery of oral thiazolidinedione nanoparticles functionalized with RGD and P3 peptides to reduce side effects and improve efficacy
|
Dr T K Praveen
|
SERB
|
45.73
|
10.
|
Design, Synthesis and Evaluation of Novel glitazones Alzehimer disease. Activation of PGC-1alpha signalling via gamma receptors
|
Dr Justin
|
DST New Delhi
|
31.5
|
11.
|
Death receptor-5 targeted lipid nanoparticles of ?- secretase inhibitor for simultaneous targeting of breast cancer cells and cancer stem cells
|
Dr Praveen T K
|
DBT Twinning Project , New Delhi
|
54.00
|
12.
|
Adipocyte specific delivery of oral thiazolidinedione nanoparticles functionalized with RGD and P3 peptides to reduce side effects and improve efficacy
|
Dr Praveen T K
|
DST -Nanomission, New Delhi
|
50.84
|
13.
|
Evaluation of neuro protective effects of nilotinib and bosutinib in experimental models of parkinsonism
|
Dr Vadivelan R
|
JSSAHER, Mysuru
|
0.25
|
14.
|
Possible Beneficial Effects of Farnesol and its Derivatives in Prevention and Treatment of Parkinson’s Disease through activation of Nrf2
|
Mr. Saravanan J, Dr. Praveen T K
|
JSSAHER, Mysuru
|
0.50
|
15.
|
Network based drug repositioning to identify hits for Alzheimers disease: Exploring the promiscuity of drugs for therapeutic benefits
|
Dr. Divakar S
|
JSSAHER, Mysuru
|
0.50
|
16.
|
CD133 mAbs surface modified carbon nanotubes loaded with surviving siRNA and Paclitaxel for the treatment of non small cell lung cancer
|
Dr Parveen T K
|
DST Indo Uzbek, New Delhi
|
117.00
|